143 related articles for article (PubMed ID: 9817290)
1. Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance.
Bradshaw DM; Arceci RJ
J Clin Oncol; 1998 Nov; 16(11):3674-90. PubMed ID: 9817290
[TBL] [Abstract][Full Text] [Related]
2. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
3. Non-P-glycoprotein drug export mechanisms of multidrug resistance.
List AF
Semin Hematol; 1997 Oct; 34(4 Suppl 5):20-4. PubMed ID: 9408957
[TBL] [Abstract][Full Text] [Related]
4. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.
Muñoz-Martínez F; Lu P; Cortés-Selva F; Pérez-Victoria JM; Jiménez IA; Ravelo AG; Sharom FJ; Gamarro F; Castanys S
Cancer Res; 2004 Oct; 64(19):7130-8. PubMed ID: 15466210
[TBL] [Abstract][Full Text] [Related]
5. Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.
Modok S; Mellor HR; Callaghan R
Curr Opin Pharmacol; 2006 Aug; 6(4):350-4. PubMed ID: 16690355
[TBL] [Abstract][Full Text] [Related]
6. Reversing agents for ATP-binding cassette drug transporters.
Lee CH
Methods Mol Biol; 2010; 596():325-40. PubMed ID: 19949930
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia.
Swerts K; De Moerloose B; Dhooge C; Laureys G; Benoit Y; Philippé J
Eur J Cancer; 2006 Feb; 42(3):295-309. PubMed ID: 16324833
[TBL] [Abstract][Full Text] [Related]
8. Molecular and pharmacological strategies to overcome multidrug resistance.
Shabbits JA; Krishna R; Mayer LD
Expert Rev Anticancer Ther; 2001 Dec; 1(4):585-94. PubMed ID: 12113091
[TBL] [Abstract][Full Text] [Related]
9. Relevance of multidrug resistance in the age of targeted therapy.
Türk D; Szakács G
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):246-52. PubMed ID: 19333870
[TBL] [Abstract][Full Text] [Related]
10. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
11. Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells.
Mo L; Pospichalova V; Huang Z; Murphy SK; Payne S; Wang F; Kennedy M; Cianciolo GJ; Bryja V; Pizzo SV; Bachelder RE
PLoS One; 2015; 10(7):e0131579. PubMed ID: 26148191
[TBL] [Abstract][Full Text] [Related]
12. Drug retention, efflux, and resistance in tumor cells.
Krishan A; Fitz CM; Andritsch I
Cytometry; 1997 Dec; 29(4):279-85. PubMed ID: 9415409
[TBL] [Abstract][Full Text] [Related]
13. [Multidrug resistance of cancer cells mediated by ABC superfamily transporters].
Ueda K
Nihon Rinsho; 1997 May; 55(5):1024-9. PubMed ID: 9155147
[TBL] [Abstract][Full Text] [Related]
14. Clinical management of recurrent breast cancer: development of multidrug resistance (MDR) and strategies to circumvent it.
Hait WN; Yang JM
Semin Oncol; 2005 Dec; 32(6 Suppl 7):S16-21. PubMed ID: 16360718
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Keshari RP; Zhang LY
Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of ATP-binding cassette transporters and clinical implications.
Cascorbi I; Haenisch S
Methods Mol Biol; 2010; 596():95-121. PubMed ID: 19949922
[TBL] [Abstract][Full Text] [Related]
17. Microparticles and their emerging role in cancer multidrug resistance.
Gong J; Jaiswal R; Mathys JM; Combes V; Grau GE; Bebawy M
Cancer Treat Rev; 2012 May; 38(3):226-34. PubMed ID: 21757296
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
[TBL] [Abstract][Full Text] [Related]
19. Poloxamines display a multiple inhibitory activity of ATP-binding cassette (ABC) transporters in cancer cell lines.
Cuestas ML; Sosnik A; Mathet VL
Mol Pharm; 2011 Aug; 8(4):1152-64. PubMed ID: 21591727
[TBL] [Abstract][Full Text] [Related]
20. [Structures and functions of xenobiotic efflux pump P-glycoprotein and MRP--important molecular targets for cancer chemotherapy].
Ueda K
Gan To Kagaku Ryoho; 1997 Dec; 24(15):2190-5. PubMed ID: 9422060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]